ncRNA name
hsa-miR-18a
Specific or universal ncRNAs
Specific ncRNAs
Class
MicroRNA
Biomarker
No
Biomarker application
Upstream regulatory factors
Not available
Downstream target
Dicer
Cancer name
Breast Cancer
Cancer site
Breast
Treatment type
Chemotherapy
Drug
Paclitaxel
Impact of wild-type ncRNA on chemotherapy resistance
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
Up
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
This study found that miR-18a is an important miRNA that suppresses Dicer expression and increases PTX resistance in TNBC cells.
Tissue resource
triple-negative breast cancer cancerous and the corresponding paired normal adjacent tissue
human triple-negative breast cancer cell lines MDAMB-231
human triple-negative breast cancer cell lines MDA-MB-468
Experiment
qRT-PCR,Western blot
Institute
the Affiliated Hospital of Qingdao University
the Cell Bank of the Chinese Academy of Sciences
Country
China
Continent
Asia